NCT04787887View on ClinicalTrials.gov

A Phase I Study to Compare Abcertin and EU-sourced Cerezyme® in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

January 29, 2020

Primary Completion Date

September 27, 2020

Study Completion Date

October 26, 2020

Conditions
Gaucher Disease
Interventions
DRUG

Abcertin

60IU/kg Single Intravenous Administration

DRUG

EU-sourced Cerezyme

60IU/kg Single Intravenous Administration

Trial Locations (1)

2031

Scientia Clinical Research Limited, Randwick

All Listed Sponsors
lead

ISU Abxis Co., Ltd.

INDUSTRY

NCT04787887 - A Phase I Study to Compare Abcertin and EU-sourced Cerezyme® in Healthy Volunteers | Biotech Hunter | Biotech Hunter